Close Menu

At his blog, Juniorprof wonders if new investigators without R01s are essentially out of luck when it comes to receiving stimulus funding. Capital improvement grants, he says, are targeted to those already with a large grant, while the challenge grants pose the problem of experience. "I can see the critique now: 'an excellent application but the lack of experience of the investigator raises the question of whether gains can be expected within 2 years,'" he writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.